NCT06594393View on ClinicalTrials.gov

A Phase 2 Study of TCP-25 Gel in Patients With Epidermolysis Bullosa, STEP-study

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

December 1, 2025

Primary Completion Date

June 30, 2027

Study Completion Date

June 30, 2027

Conditions
Epidermolysis Bullosa (EB)
Interventions
DRUG

TCP-25 gel

Topical gel

DRUG

Vehicle (placebo)

Placebo gel

Trial Locations (1)

23735

University hospital, Lund

All Listed Sponsors
lead

Xinnate AB

INDUSTRY